APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Erectile Dysfunction Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Erectile Dysfunction Medication Market Analysis and Forecast 2026-2032

Report ID 173989250231 December 2025193 pages

Choose your research edition.

Industry ResearchErectile Dysfunction Medication Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Erectile Dysfunction Medication Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Erectile Dysfunction Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Erectile Dysfunction Medication Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Erectile Dysfunction Medication Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Erectile Dysfunction Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Erectile Dysfunction Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Erectile Dysfunction Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Erectile Dysfunction Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Erectile Dysfunction Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Erectile Dysfunction Medication include Chongqing Huapont, Chiatai Tianqing, Yabang Pharmacy, Humanwell, Qilu Pharmaceutical, Pfizer, Guangzhou Hairui Pharmaceutical, Guangzhou Baiyunshan and Hebei Changshan Biochemical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Erectile Dysfunction Medication, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Erectile Dysfunction Medication, also provides the revenue of main regions and countries. Of the upcoming market potential for Erectile Dysfunction Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Erectile Dysfunction Medication revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Erectile Dysfunction Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Erectile Dysfunction Medication revenue, projected growth trends, production technology, application and end-user industry.

Erectile Dysfunction Medication Segment by Company

Chongqing Huapont

Chiatai Tianqing

Yabang Pharmacy

Humanwell

Qilu Pharmaceutical

Pfizer

Guangzhou Hairui Pharmaceutical

Guangzhou Baiyunshan

Hebei Changshan Biochemical

Bayer

Lilly

Jiangsu Tasly

Diao

Erectile Dysfunction Medication Segment by Type

Stendra

Levitra

Cialis

Viagra

Erectile Dysfunction Medication Segment by Application

Pharmaceutical E-commerce

Medical Institutions

Pharmacies

Erectile Dysfunction Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Erectile Dysfunction Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Erectile Dysfunction Medication company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Medication revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Erectile Dysfunction Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stendra Major Player Table 3. Levitra Major Player Table 4. Cialis Major Player Table 5. Viagra Major Player Table 6. Global Erectile Dysfunction Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical E-commerce Major Player Table 8. Medical Institutions Major Player Table 9. Pharmacies Major Player Table 10. Erectile Dysfunction Medication Industry Trends Table 11. Erectile Dysfunction Medication Industry Drivers Table 12. Erectile Dysfunction Medication Industry Opportunities and Challenges Table 13. Erectile Dysfunction Medication Industry Restraints Table 14. Global Erectile Dysfunction Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Erectile Dysfunction Medication Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Erectile Dysfunction Medication Market Share by Region (2021-2026) Table 17. Global Erectile Dysfunction Medication Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Erectile Dysfunction Medication Market Share by Region (2027-2032) Table 19. Global Erectile Dysfunction Medication Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Erectile Dysfunction Medication Revenue Market Share by Players (2021-2026) Table 21. Global Erectile Dysfunction Medication Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Erectile Dysfunction Medication Key Players Headquarters & Area Served Table 23. Global Erectile Dysfunction Medication Players, Product Type & Application Table 24. Global Erectile Dysfunction Medication Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Erectile Dysfunction Medication by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Erectile Dysfunction Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Erectile Dysfunction Medication Revenue Market Share by Type (2021-2026) Table 31. Global Erectile Dysfunction Medication Revenue Market Share by Type (2027-2032) Table 32. Global Erectile Dysfunction Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Erectile Dysfunction Medication Revenue Market Share by Application (2021-2026) Table 36. Global Erectile Dysfunction Medication Revenue Market Share by Application (2027-2032) Table 37. Chongqing Huapont Company Information Table 38. Chongqing Huapont Business Overview Table 39. Chongqing Huapont Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Chongqing Huapont Erectile Dysfunction Medication Product Portfolio Table 41. Chongqing Huapont Recent Development Table 42. Chiatai Tianqing Company Information Table 43. Chiatai Tianqing Business Overview Table 44. Chiatai Tianqing Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Chiatai Tianqing Erectile Dysfunction Medication Product Portfolio Table 46. Chiatai Tianqing Recent Development Table 47. Yabang Pharmacy Company Information Table 48. Yabang Pharmacy Business Overview Table 49. Yabang Pharmacy Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Yabang Pharmacy Erectile Dysfunction Medication Product Portfolio Table 51. Yabang Pharmacy Recent Development Table 52. Humanwell Company Information Table 53. Humanwell Business Overview Table 54. Humanwell Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Humanwell Erectile Dysfunction Medication Product Portfolio Table 56. Humanwell Recent Development Table 57. Qilu Pharmaceutical Company Information Table 58. Qilu Pharmaceutical Business Overview Table 59. Qilu Pharmaceutical Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Qilu Pharmaceutical Erectile Dysfunction Medication Product Portfolio Table 61. Qilu Pharmaceutical Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pfizer Erectile Dysfunction Medication Product Portfolio Table 66. Pfizer Recent Development Table 67. Guangzhou Hairui Pharmaceutical Company Information Table 68. Guangzhou Hairui Pharmaceutical Business Overview Table 69. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Product Portfolio Table 71. Guangzhou Hairui Pharmaceutical Recent Development Table 72. Guangzhou Baiyunshan Company Information Table 73. Guangzhou Baiyunshan Business Overview Table 74. Guangzhou Baiyunshan Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Guangzhou Baiyunshan Erectile Dysfunction Medication Product Portfolio Table 76. Guangzhou Baiyunshan Recent Development Table 77. Hebei Changshan Biochemical Company Information Table 78. Hebei Changshan Biochemical Business Overview Table 79. Hebei Changshan Biochemical Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Hebei Changshan Biochemical Erectile Dysfunction Medication Product Portfolio Table 81. Hebei Changshan Biochemical Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Erectile Dysfunction Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Bayer Erectile Dysfunction Medication Product Portfolio Table 86. Bayer Recent Development Table 87. Lilly Company Information Table 88. Lilly Business Overview Table 89. Lilly Erectile Dysfunction Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lilly Erectile Dysfunction Medication Product Portfolio Table 91. Lilly Recent Development Table 92. Jiangsu Tasly Company Information Table 93. Jiangsu Tasly Business Overview Table 94. Jiangsu Tasly Erectile Dysfunction Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jiangsu Tasly Erectile Dysfunction Medication Product Portfolio Table 96. Jiangsu Tasly Recent Development Table 97. Diao Company Information Table 98. Diao Business Overview Table 99. Diao Erectile Dysfunction Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Diao Erectile Dysfunction Medication Product Portfolio Table 101. Diao Recent Development Table 102. North America Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Erectile Dysfunction Medication Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Erectile Dysfunction Medication Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Erectile Dysfunction Medication Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Erectile Dysfunction Medication Revenue by Country (US$ Million) & (2027-2032) Table 116. China Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 117. China Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 118. China Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 119. China Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Erectile Dysfunction Medication Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Erectile Dysfunction Medication Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Erectile Dysfunction Medication Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Erectile Dysfunction Medication Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Erectile Dysfunction Medication Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Erectile Dysfunction Medication Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Erectile Dysfunction Medication Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Erectile Dysfunction Medication Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Erectile Dysfunction Medication Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Erectile Dysfunction Medication Image Figure 2. Global Erectile Dysfunction Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Erectile Dysfunction Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stendra Image Figure 5. Levitra Image Figure 6. Cialis Image Figure 7. Viagra Image Figure 8. Global Erectile Dysfunction Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Erectile Dysfunction Medication Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical E-commerce Image Figure 11. Medical Institutions Image Figure 12. Pharmacies Image Figure 13. Global Erectile Dysfunction Medication Market Size (US$ Million) & (2021-2032) Figure 14. Global Erectile Dysfunction Medication Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Erectile Dysfunction Medication Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Erectile Dysfunction Medication Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Erectile Dysfunction Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Erectile Dysfunction Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Erectile Dysfunction Medication Revenue Market Share by Type (2021-2032) Figure 21. Global Erectile Dysfunction Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Erectile Dysfunction Medication Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Erectile Dysfunction Medication Revenue Market Share by Application (2021-2032) Figure 24. North America Erectile Dysfunction Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Erectile Dysfunction Medication Revenue Share by Type (2021-2032) Figure 26. North America Erectile Dysfunction Medication Revenue Share by Application (2021-2032) Figure 27. North America Erectile Dysfunction Medication Revenue Share by Country (2021-2032) Figure 28. United States Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Erectile Dysfunction Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Erectile Dysfunction Medication Revenue Share by Type (2021-2032) Figure 33. Europe Erectile Dysfunction Medication Revenue Share by Application (2021-2032) Figure 34. Europe Erectile Dysfunction Medication Revenue Share by Country (2021-2032) Figure 35. Germany Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Erectile Dysfunction Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Erectile Dysfunction Medication Revenue Share by Type (2021-2032) Figure 45. China Erectile Dysfunction Medication Revenue Share by Application (2021-2032) Figure 46. Asia Erectile Dysfunction Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Erectile Dysfunction Medication Revenue Share by Type (2021-2032) Figure 48. Asia Erectile Dysfunction Medication Revenue Share by Application (2021-2032) Figure 49. Asia Erectile Dysfunction Medication Revenue Share by Region (2021-2032) Figure 50. Japan Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Erectile Dysfunction Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Erectile Dysfunction Medication Revenue Share by Type (2021-2032) Figure 58. SAMEA Erectile Dysfunction Medication Revenue Share by Application (2021-2032) Figure 59. SAMEA Erectile Dysfunction Medication Revenue Share by Country (2021-2032) Figure 60. Brazil Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Erectile Dysfunction Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Stendra
  • Levitra
  • Cialis
  • Viagra
Applications
  • Pharmaceutical E-commerce
  • Medical Institutions
  • Pharmacies
Companies covered
  • Chongqing Huapont
  • Chiatai Tianqing
  • Yabang Pharmacy
  • Humanwell
  • Qilu Pharmaceutical
  • Pfizer
  • Guangzhou Hairui Pharmaceutical
  • Guangzhou Baiyunshan
  • Hebei Changshan Biochemical
  • Bayer
  • Lilly
  • Jiangsu Tasly
  • Diao

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Erectile Dysfunction Medication Market by Type
  3. 1.2.1 Global Erectile Dysfunction Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stendra
  5. 1.2.3 Levitra
  6. 1.2.4 Cialis
  7. 1.2.5 Viagra
  8. 1.3 Erectile Dysfunction Medication Market by Application
  9. 1.3.1 Global Erectile Dysfunction Medication Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical E-commerce
  11. 1.3.3 Medical Institutions
  12. 1.3.4 Pharmacies
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Erectile Dysfunction Medication Market Dynamics
  1. 2.1 Erectile Dysfunction Medication Industry Trends
  2. 2.2 Erectile Dysfunction Medication Industry Drivers
  3. 2.3 Erectile Dysfunction Medication Industry Opportunities and Challenges
  4. 2.4 Erectile Dysfunction Medication Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Erectile Dysfunction Medication Market Perspective (2021-2032)
  2. 3.2 Global Erectile Dysfunction Medication Growth Trends by Region
  3. 3.2.1 Global Erectile Dysfunction Medication Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Erectile Dysfunction Medication Market Size by Region (2021-2026)
  5. 3.2.3 Global Erectile Dysfunction Medication Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Erectile Dysfunction Medication Revenue by Players
  2. 4.1.1 Global Erectile Dysfunction Medication Revenue by Players (2021-2026)
  3. 4.1.2 Global Erectile Dysfunction Medication Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Erectile Dysfunction Medication Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Erectile Dysfunction Medication Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Erectile Dysfunction Medication Key Players Headquarters & Area Served
  7. 4.4 Global Erectile Dysfunction Medication Players, Product Type & Application
  8. 4.5 Global Erectile Dysfunction Medication Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Erectile Dysfunction Medication Market CR5 and HHI
  11. 4.6.3 2025 Erectile Dysfunction Medication Tier 1, Tier 2, and Tier 3
5 Erectile Dysfunction Medication Market Size by Type
  1. 5.1 Global Erectile Dysfunction Medication Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 5.3 Global Erectile Dysfunction Medication Revenue Market Share by Type (2021-2032)
6 Erectile Dysfunction Medication Market Size by Application
  1. 6.1 Global Erectile Dysfunction Medication Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Erectile Dysfunction Medication Revenue by Application (2021-2032)
  3. 6.3 Global Erectile Dysfunction Medication Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Chongqing Huapont
  2. 7.1.1 Chongqing Huapont Company Information
  3. 7.1.2 Chongqing Huapont Business Overview
  4. 7.1.3 Chongqing Huapont Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Huapont Erectile Dysfunction Medication Product Portfolio
  6. 7.1.5 Chongqing Huapont Recent Developments
  7. 7.2 Chiatai Tianqing
  8. 7.2.1 Chiatai Tianqing Company Information
  9. 7.2.2 Chiatai Tianqing Business Overview
  10. 7.2.3 Chiatai Tianqing Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Chiatai Tianqing Erectile Dysfunction Medication Product Portfolio
  12. 7.2.5 Chiatai Tianqing Recent Developments
  13. 7.3 Yabang Pharmacy
  14. 7.3.1 Yabang Pharmacy Company Information
  15. 7.3.2 Yabang Pharmacy Business Overview
  16. 7.3.3 Yabang Pharmacy Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Yabang Pharmacy Erectile Dysfunction Medication Product Portfolio
  18. 7.3.5 Yabang Pharmacy Recent Developments
  19. 7.4 Humanwell
  20. 7.4.1 Humanwell Company Information
  21. 7.4.2 Humanwell Business Overview
  22. 7.4.3 Humanwell Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Humanwell Erectile Dysfunction Medication Product Portfolio
  24. 7.4.5 Humanwell Recent Developments
  25. 7.5 Qilu Pharmaceutical
  26. 7.5.1 Qilu Pharmaceutical Company Information
  27. 7.5.2 Qilu Pharmaceutical Business Overview
  28. 7.5.3 Qilu Pharmaceutical Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Qilu Pharmaceutical Erectile Dysfunction Medication Product Portfolio
  30. 7.5.5 Qilu Pharmaceutical Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Erectile Dysfunction Medication Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Guangzhou Hairui Pharmaceutical
  38. 7.7.1 Guangzhou Hairui Pharmaceutical Company Information
  39. 7.7.2 Guangzhou Hairui Pharmaceutical Business Overview
  40. 7.7.3 Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Product Portfolio
  42. 7.7.5 Guangzhou Hairui Pharmaceutical Recent Developments
  43. 7.8 Guangzhou Baiyunshan
  44. 7.8.1 Guangzhou Baiyunshan Company Information
  45. 7.8.2 Guangzhou Baiyunshan Business Overview
  46. 7.8.3 Guangzhou Baiyunshan Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Guangzhou Baiyunshan Erectile Dysfunction Medication Product Portfolio
  48. 7.8.5 Guangzhou Baiyunshan Recent Developments
  49. 7.9 Hebei Changshan Biochemical
  50. 7.9.1 Hebei Changshan Biochemical Company Information
  51. 7.9.2 Hebei Changshan Biochemical Business Overview
  52. 7.9.3 Hebei Changshan Biochemical Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hebei Changshan Biochemical Erectile Dysfunction Medication Product Portfolio
  54. 7.9.5 Hebei Changshan Biochemical Recent Developments
  55. 7.10 Bayer
  56. 7.10.1 Bayer Company Information
  57. 7.10.2 Bayer Business Overview
  58. 7.10.3 Bayer Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bayer Erectile Dysfunction Medication Product Portfolio
  60. 7.10.5 Bayer Recent Developments
  61. 7.11 Lilly
  62. 7.11.1 Lilly Company Information
  63. 7.11.2 Lilly Business Overview
  64. 7.11.3 Lilly Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lilly Erectile Dysfunction Medication Product Portfolio
  66. 7.11.5 Lilly Recent Developments
  67. 7.12 Jiangsu Tasly
  68. 7.12.1 Jiangsu Tasly Company Information
  69. 7.12.2 Jiangsu Tasly Business Overview
  70. 7.12.3 Jiangsu Tasly Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Jiangsu Tasly Erectile Dysfunction Medication Product Portfolio
  72. 7.12.5 Jiangsu Tasly Recent Developments
  73. 7.13 Diao
  74. 7.13.1 Diao Company Information
  75. 7.13.2 Diao Business Overview
  76. 7.13.3 Diao Erectile Dysfunction Medication Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Diao Erectile Dysfunction Medication Product Portfolio
  78. 7.13.5 Diao Recent Developments
8 North America
  1. 8.1 North America Erectile Dysfunction Medication Revenue (2021-2032)
  2. 8.2 North America Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 8.2.1 North America Erectile Dysfunction Medication Revenue by Type (2021-2026)
  4. 8.2.2 North America Erectile Dysfunction Medication Revenue by Type (2027-2032)
  5. 8.3 North America Erectile Dysfunction Medication Revenue Share by Type (2021-2032)
  6. 8.4 North America Erectile Dysfunction Medication Revenue by Application (2021-2032)
  7. 8.4.1 North America Erectile Dysfunction Medication Revenue by Application (2021-2026)
  8. 8.4.2 North America Erectile Dysfunction Medication Revenue by Application (2027-2032)
  9. 8.5 North America Erectile Dysfunction Medication Revenue Share by Application (2021-2032)
  10. 8.6 North America Erectile Dysfunction Medication Revenue by Country
  11. 8.6.1 North America Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Erectile Dysfunction Medication Revenue by Country (2021-2026)
  13. 8.6.3 North America Erectile Dysfunction Medication Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Erectile Dysfunction Medication Revenue (2021-2032)
  2. 9.2 Europe Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 9.2.1 Europe Erectile Dysfunction Medication Revenue by Type (2021-2026)
  4. 9.2.2 Europe Erectile Dysfunction Medication Revenue by Type (2027-2032)
  5. 9.3 Europe Erectile Dysfunction Medication Revenue Share by Type (2021-2032)
  6. 9.4 Europe Erectile Dysfunction Medication Revenue by Application (2021-2032)
  7. 9.4.1 Europe Erectile Dysfunction Medication Revenue by Application (2021-2026)
  8. 9.4.2 Europe Erectile Dysfunction Medication Revenue by Application (2027-2032)
  9. 9.5 Europe Erectile Dysfunction Medication Revenue Share by Application (2021-2032)
  10. 9.6 Europe Erectile Dysfunction Medication Revenue by Country
  11. 9.6.1 Europe Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Erectile Dysfunction Medication Revenue by Country (2021-2026)
  13. 9.6.3 Europe Erectile Dysfunction Medication Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Erectile Dysfunction Medication Revenue (2021-2032)
  2. 10.2 China Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 10.2.1 China Erectile Dysfunction Medication Revenue by Type (2021-2026)
  4. 10.2.2 China Erectile Dysfunction Medication Revenue by Type (2027-2032)
  5. 10.3 China Erectile Dysfunction Medication Revenue Share by Type (2021-2032)
  6. 10.4 China Erectile Dysfunction Medication Revenue by Application (2021-2032)
  7. 10.4.1 China Erectile Dysfunction Medication Revenue by Application (2021-2026)
  8. 10.4.2 China Erectile Dysfunction Medication Revenue by Application (2027-2032)
  9. 10.5 China Erectile Dysfunction Medication Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Erectile Dysfunction Medication Revenue (2021-2032)
  2. 11.2 Asia Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 11.2.1 Asia Erectile Dysfunction Medication Revenue by Type (2021-2026)
  4. 11.2.2 Asia Erectile Dysfunction Medication Revenue by Type (2027-2032)
  5. 11.3 Asia Erectile Dysfunction Medication Revenue Share by Type (2021-2032)
  6. 11.4 Asia Erectile Dysfunction Medication Revenue by Application (2021-2032)
  7. 11.4.1 Asia Erectile Dysfunction Medication Revenue by Application (2021-2026)
  8. 11.4.2 Asia Erectile Dysfunction Medication Revenue by Application (2027-2032)
  9. 11.5 Asia Erectile Dysfunction Medication Revenue Share by Application (2021-2032)
  10. 11.6 Asia Erectile Dysfunction Medication Revenue by Country
  11. 11.6.1 Asia Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Erectile Dysfunction Medication Revenue by Country (2021-2026)
  13. 11.6.3 Asia Erectile Dysfunction Medication Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Erectile Dysfunction Medication Revenue (2021-2032)
  2. 12.2 SAMEA Erectile Dysfunction Medication Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Erectile Dysfunction Medication Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Erectile Dysfunction Medication Revenue by Type (2027-2032)
  5. 12.3 SAMEA Erectile Dysfunction Medication Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Erectile Dysfunction Medication Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Erectile Dysfunction Medication Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Erectile Dysfunction Medication Revenue by Application (2027-2032)
  9. 12.5 SAMEA Erectile Dysfunction Medication Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Erectile Dysfunction Medication Revenue by Country
  11. 12.6.1 SAMEA Erectile Dysfunction Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Erectile Dysfunction Medication Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Erectile Dysfunction Medication Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst